Passionate about
patient WellBeing

Learn More

New treatment options widen the possibility that each patient can obtain the right solution for improving their wellbeing. XenoPort is passionate about our pursuit of better treatment options for patients.  We focus our efforts on treatments for neurological disorders.

New treatment options widen the possibility that each patient can obtain the right solution for improving their wellbeing. XenoPort is passionate about our pursuit of better treatment options for patients.  We focus our efforts on treatments for neurological disorders.

HORIZANT Offers an Option to Patients

HORIZANT’s U.S. FDA approval in April 2011 provided a new treatment option to patients.

Learn More
Horizant

Latest News and Events

Thu, 16 Jun 2016

Arbor Pharmaceuticals and XenoPort Announce the Expiration of the HSR Act Waiting Period

Read Story
More News

Our Product Candidates and Partners

Our product candidates offer unique properties that we believe could enhance treatment benefits to patients.

View Candidates